ロード中...
Evaluating the Impact of Oncology Care Model Reporting Requirements on Biomarker Testing and Treatment
PURPOSE: The Oncology Care Model (OCM) is Medicare’s first alternative payment model program for patients with cancer. As of October 2017, participating practices were required to report biomarker testing of patients with advanced non–small-cell lung cancer (aNSCLC). Our objective was to evaluate th...
保存先:
| 出版年: | JCO Oncol Pract |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Clinical Oncology
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564129/ https://ncbi.nlm.nih.gov/pubmed/32496874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.19.00747 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|